HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sreedhar R Nallapareddy Selected Research

Collagen

1/2013Contribution of individual Ebp Pilus subunits of Enterococcus faecalis OG1RF to pilus biogenesis, biofilm formation and urinary tract infection.
7/2011Relative contributions of Ebp Pili and the collagen adhesin ace to host extracellular matrix protein adherence and experimental urinary tract infection by Enterococcus faecalis OG1RF.
1/2010Importance of the collagen adhesin ace in pathogenesis and protection against Enterococcus faecalis experimental endocarditis.
9/2008Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis.
9/2008A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen.
3/2002Molecular typing of selected Enterococcus faecalis isolates: pilot study using multilocus sequence typing and pulsed-field gel electrophoresis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sreedhar R Nallapareddy Research Topics

Disease

12Endocarditis
01/2013 - 03/2002
5Infections
01/2010 - 03/2003
3Urinary Tract Infections (Urinary Tract Infection)
01/2013 - 11/2007
2Bacterial Endocarditis
10/2006 - 09/2006
1Cross Infection (Nosocomial Infection)
10/2008

Drug/Important Bio-Agent (IBA)

6CollagenIBA
01/2013 - 03/2002
3Proteins (Proteins, Gene)FDA Link
09/2006 - 07/2004
2Fibrinogen (Factor I)FDA Link
01/2013 - 07/2011
2Virulence Factors (Pathogenicity Factors)IBA
09/2011 - 03/2003
2Extracellular Matrix ProteinsIBA
07/2011 - 12/2008
2AntibodiesIBA
09/2008 - 07/2004
21- (5'- O- sulfamoyl- beta- ribofuranosyl)(1,2,4)triazole- 3- thiocarboxamideIBA
11/2007 - 10/2006
2Collagen Type I (Type I Collagen)IBA
01/2006 - 03/2003
1salicylhydroxamic acid (SHAM)IBA
01/2010
1Anti-Bacterial Agents (Antibiotics)IBA
10/2008
1Immunoglobulins (Immunoglobulin)IBA
09/2006
1Fibronectins (Fibronectin)IBA
01/2006
1GelatinasesIBA
08/2005
1protease SIBA
08/2005
1Serine Proteases (Serine Protease)IBA
08/2005
1VancomycinFDA LinkGeneric
03/2003
1AntigensIBA
03/2002
1Laminin (Merosin)IBA
03/2002

Therapy/Procedure

1Immunotherapy
10/2006